[Pulmonary arterial hypertension].
Reichenberger
F
F
Pneumologie Med. Klinik II, Universitätsklinikum Giessen Marburg GmbH, Standort Giessen. frank.reichenberger@innere.med.uni-giessen.de
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D058986:Phosphodiesterase 5 Inhibitors; D011453:Prostaglandins / Q000627:therapeutic use; D012307:Risk Factors
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D011453:Prostaglandins